Orion Biotech Opportunities Corp.
Orion Biotech Opportunities Corp. is grouped at the issuer level across 1 linked ticker lifecycle, combining public listing, delisting, source, and shareholder outcome records from the archive.
Lifecycle Map
Issuer enters the archive
Feb 25, 2021Orion Biotech Opportunities Corp. is represented as an issuer-level entity with 1 linked public-market ticker lifecycle.
Delisting event
May 1, 2023SEC 25 delisting filing validated by CIK/company-name LLM pass.
SourceONTX stopped trading
May 1, 2023ONTX is linked to Orion Biotech Opportunities Corp. and ended with final status "private".
Source
Entity Graph
Orion Biotech Opportunities Corp.issuedONTX
ONTXlisted onNASDAQ
ONTXresulted inunknown
Source-Backed Claims
- On April 24, 2023, Orion Biotech Opportunities Corp. announced that its publicly held Class A ordinary shares will be deemed cancelled as of May 17, 2023.8-K
- The Class A ordinary shares of Orion Biotech Opportunities Corp. will only represent the right to receive a pro-rata share of the Company's trust account after cancellation.8-K
- Orion Biotech Opportunities Corp. will not consummate an initial business combination within the required time period as per its Amended and Restated Memorandum and Articles of Association.8-K
- The sponsor of Orion Biotech Opportunities Corp. has agreed to waive its redemption rights concerning its outstanding Class B ordinary shares issued prior to the Company's initial public offering.8-K
- There will be no redemption rights or liquidating distributions with respect to Orion Biotech Opportunities Corp.'s warrants, which will expire worthless.8-K
- Orion Biotech Opportunities Corp. intends to file a Form 25 with the SEC to delist its securities.8-K
- Following the Form 25 filing, Orion Biotech Opportunities Corp. expects to file a Form 15 to terminate the registration of its securities under the Securities Exchange Act of 1934.8-K
Associated Tickers
Public-market security lifecycles tied to this issuer record.